Thursday, 22 March 2018: POSTER SESSION: Systemic Treatment: Poster
338 (PB-133) - Loss of HER2 amplification and disease prognosis after neoadjuvant treatment of HER2 amplified breast cancer

https://doi.org/10.1016/S0959-8049(18)30510-0Get rights and content

References (0)

Cited by (0)

View full text